Back to UBS Group AG UBS Group AG

ZVSAZVSA
5 quarters

Position history for UBS Group AGUBS Group AG's holdings in ZyVersa Therapeutics, Inc.

UBS Group AG previously held 0 shares of ZVSA (ZyVersa Therapeutics, Inc.), worth $0 as of 2025-Q3.

Final Value

$0

Final Shares

0

Total Value Change

-$1,039

Total Shares Change

-433

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q3
Latest
Exited
0
-100.0%
$00.0%$0.14
0
2025-Q2
Increased
39,280
+38.7%
$26,5930.0%$0.71
17
2025-Q1
Increased
28,327
+576.5%
$17,8180.0%$0.61
20
2024-Q4
Increased
4,187
+867.0%
$4,4380.0%$1.07
16
2024-Q3
New
433
-
$1,0390.0%$2.36
17

Other major holders of ZVSA: CITIGROUP INC, Virtu Financial LLC, GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used